EcoDrugPlus

Aurora Kinase B-Like

Ensembl ID : ENSPLAG00000006058
Gene Symbol: LOC106963144
3 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSPLAG00000006765
Gene Symbol: LOC106934467
3 Cross references
226 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSPLAG00000019528
Gene Symbol: LOC106955420
3 Cross references
195 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSPLAG00000011405
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSPLAG00000023604
Gene Symbol: BDKRB1
1 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSPLAG00000009260
Gene Symbol: BDKRB2
2 Cross references
161 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSPLAG00000023571
Gene Symbol: BDKRB2
1 Cross references
245 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSPLAG00000023542
Gene Symbol: BDKRB2
1 Cross references
242 Possible Orthologues:

Breakpoint Cluster Region Protein-Like

Ensembl ID : ENSPLAG00000002632
Gene Symbol: LOC106940419
2 Cross references
13 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b-Like

Ensembl ID : ENSPLAG00000008594
Gene Symbol: LOC106946583
2 Cross references
224 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4c-Like

Ensembl ID : ENSPLAG00000022949
Gene Symbol: LOC106948707
2 Cross references
193 Possible Orthologues:

Cgmp-Specific 3',5'-Cyclic Phosphodiesterase-Like

Ensembl ID : ENSPLAG00000019569
Gene Symbol: LOC106954676
2 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).